Here is a comprehensive treatment summary for conjunctivitis, organized by type:
Treatment of Conjunctivitis
1. Bacterial Conjunctivitis
General Principle
About 60% resolve within 5 days without treatment. Antibiotics shorten the course and reduce transmission but are not always mandatory.
Topical Antibiotics (first-line options)
Use QID for up to 1 week. Ointments provide higher concentration and longer contact time but blur vision — reserve for nighttime use.
| Agent | Notes |
|---|
| Trimethoprim–polymyxin B | Preferred first-line; avoids sulfa/neomycin allergy risk |
| Erythromycin / Bacitracin ointment | Broad coverage, well tolerated |
| Tobramycin | Good gram-positive and gram-negative coverage |
| Ciprofloxacin / Ofloxacin | Broad-spectrum fluoroquinolones |
| Gatifloxacin / Moxifloxacin / Besifloxacin | Newer fluoroquinolones; better gram-positive penetration |
| Chloramphenicol | Widely used outside USA; some practitioners avoid due to rare aplastic anaemia risk |
| Fusidic acid | Option in some guidelines |
Contact lens wearers: Use a fluoroquinolone or tobramycin to cover Pseudomonas.
If no improvement in 2–3 days or worsening, refer to ophthalmologist. Culture discharge in severe cases.
Systemic Antibiotics — Required For:
| Organism | Systemic Treatment |
|---|
| N. gonorrhoeae | Ceftriaxone (preferred in adults); quinolones or macrolides are alternatives. Seek genitourinary specialist input |
| H. influenzae | Oral amoxicillin–clavulanic acid (25% risk of otitis/systemic spread in children) |
| N. meningitidis | IM benzylpenicillin, ceftriaxone, or cefotaxime — do not delay; up to 30% develop systemic disease |
| Trachoma | Systemic azithromycin (with specialist consultation) |
Gonococcal/meningococcal: Also give topical antibiotic 1–2 hourly initially (quinolone, gentamicin, chloramphenicol, or bacitracin) in addition to systemic therapy.
Supportive
- Irrigation with normal saline to clear excessive discharge in hyperpurulent cases
- Discontinue contact lenses until 48 hours after complete symptom resolution
2. Viral Conjunctivitis
Largely self-limited (1–3 weeks). No specific antivirals except for herpetic involvement.
| Measure | Details |
|---|
| Cool compresses | Several times daily for comfort |
| Artificial tears | 5–6 times/day |
| Topical decongestant | e.g., Naphcon-A 1 drop TID PRN for redness |
| Topical antibiotics | Not routinely indicated; prescribe only if bacterial vs. viral distinction is uncertain pending ophthalmology review |
| Topical steroids | Avoid — prolongs viral infection and risks corneal herpetic penetration |
Herpes keratitis (HSV): Topical acyclovir 5% ointment — requires ophthalmology or infectious disease consultation.
Infection Control (critical)
- Frequent handwashing; separate towels
- Examiner wears gloves; disinfect slit lamp and examination surfaces
- No evidence-based medical reason to exclude from school/daycare, though many institutions mandate antibiotics before return
3. Allergic Conjunctivitis
Non-pharmacological
- Identify and eliminate the allergen
- Cool compresses QID
- Keep windows closed during allergy season; wash face/hair after outdoors; avoid touching eyes
Pharmacological (stepwise)
| Severity | Treatment |
|---|
| Mild | Artificial tears alone; oral non-sedating antihistamine |
| Moderate | Topical antihistamine–decongestant (naphazoline–pheniramine [Naphcon-A]) — note: rebound vasodilation can occur with prolonged use |
| Moderate–Severe | Topical mast cell stabilizer: cromolyn sodium 4%, pemirolast (QID during allergy season); dual-action antihistamine + mast cell stabilizer: olopatadine (Patanol), ketotifen, azelastine (Optivar) |
| Moderate | Topical NSAIDs: ketorolac (Acular), lodoxamide (Alomide) |
| Severe | Topical corticosteroids — only with ophthalmology consultation (risk of herpetic infection, glaucoma, cataracts, fungal ulcer) |
| Refractory | Allergy testing and immunotherapy (desensitization shots) |
For concomitant allergic rhinoconjunctivitis: topical cromolyn sodium or topical antihistamines (olopatadine, azelastine, ketotifen, epinastine) are effective.
4. Neonatal Conjunctivitis (Ophthalmia Neonatorum)
| Type | Onset | Treatment |
|---|
| Chemical (silver nitrate prophylaxis) | Day 1 | None — self-resolves |
| Gonococcal | Days 3–5 | IV/IM cefotaxime 50 mg/kg (preferred over ceftriaxone in neonates — avoids bilirubin displacement and kernicterus); admit + ophthalmology consult; irrigate with NS; topical alone is inadequate |
| Chlamydial | End of week 1 – 1 month | Oral erythromycin 50 mg/kg/day ÷ QID × 14 days; treat mother and partners; topical unnecessary |
| HSV | Variable | Full sepsis evaluation; IV acyclovir 20 mg/kg/dose TID |
Key Contraindication
Topical corticosteroids should not be used for conjunctivitis outside ophthalmologist supervision due to risk of:
- Herpetic corneal perforation
- Steroid-induced open-angle glaucoma
- Cataracts
- Fungal corneal ulcer
— Kanski's Clinical Ophthalmology, Tintinalli's Emergency Medicine, Textbook of Family Medicine 9e, Rosen's Emergency Medicine